Medication info
Alonate Plus Tablet

Alonate Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Hydrate›91.37mg / 1 tabletCholecalciferol Concentrate Powder›53.33mg / 1 tablet
Manufacturer / importer
Farm Gen Science Co., Ltd.
Appearance
White to light yellow rectangular tablets
Packaging
4 tablets/Alu-Alu
Approval status
Active

MFDS item code 201405282 · Approved 2014.11.12 · Insurance code 670103710

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with a sufficient amount of water, at least 30 minutes before eating, drinking, or taking any other medicine (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data over 4 years. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuation should be considered after 3~5 years of treatment. Patients who discontinue treatment should be reassessed periodically for their risk of fracture. Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see “Interactions”). If food is taken within 30 minutes after taking this medicine or at the same time, alendronate absorption in the body may be reduced, decreasing its effect. This medicine should be taken as soon as the patient gets up in the morning, with a sufficient amount of water (170∼230 mL), to facilitate rapid passage of the medicine into the stomach and reduce the possibility of esophageal irritation. After taking it, the patient should not lie down for at least 30 minutes and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these directions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients who do not get sufficient calcium and vitamin D from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. With once-weekly dosing, this medicine provides a week's supply of daily vitamin D at 400 IU or 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, then resume taking it on the originally scheduled day and continue taking it regularly once weekly thereafter. However, do not take 2 tablets on the same day. Administration to elderly patients (65 years and older): No dose adjustment is required. Administration to patients with renal impairment: No dose adjustment is required for patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min); however, administration of this medicine is not recommended for patients with severe renal impairment (creatinine clearance less than 35 mL/min) because there is insufficient clinical experience.
Child dose
Children and adolescents (under 18 years): The safety and efficacy in children and adolescents have not been established.

Ingredients

Manufacturer
Farm Gen Science Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

Used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with a sufficient amount of water, at least 30 minutes before eating, drinking, or taking any other medicine (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data over 4 years. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuation should be considered after 3~5 years of treatment. Patients who discontinue treatment should be reassessed periodically for their risk of fracture. Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see “Interactions”). If food is taken within 30 minutes after taking this medicine or at the same time, alendronate absorption in the body may be reduced, decreasing its effect. This medicine should be taken as soon as the patient gets up in the morning, with a sufficient amount of water (170∼230 mL), to facilitate rapid passage of the medicine into the stomach and reduce the possibility of esophageal irritation. After taking it, the patient should not lie down for at least 30 minutes and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these directions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients who do not get sufficient calcium and vitamin D from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. With once-weekly dosing, this medicine provides a week's supply of daily vitamin D at 400 IU or 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, then resume taking it on the originally scheduled day and continue taking it regularly once weekly thereafter. However, do not take 2 tablets on the same day. Administration to elderly patients (65 years and older): No dose adjustment is required. Administration to patients with renal impairment: No dose adjustment is required for patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min); however, administration of this medicine is not recommended for patients with severe renal impairment (creatinine clearance less than 35 mL/min) because there is insufficient clinical experience.

Child dose

Children and adolescents (under 18 years): The safety and efficacy in children and adolescents have not been established.

Precautions

This medication can irritate the gastrointestinal mucosa, which may lead to esophageal issues such as esophagitis, esophageal ulcers, and esophageal erosions. It should be taken with a sufficient amount of water, and patients should not lie down for at least 30 minutes after taking it. If symptoms such as issues with the esophagus, dysphagia, odynophagia, pain behind the chest, or heartburn occur, discontinue use immediately and consult a doctor. This medication is not prescribed for patients with esophageal motility disorders or those who cannot sit or stand for more than 30 minutes. Patients with allergies to any ingredients or those with hypocalcemia should also avoid this medication. During treatment, gastrointestinal side effects such as abdominal pain, dyspepsia, nausea, diarrhea, and constipation may occur, and caution is advised. Neurological symptoms such as muscle or joint pain, headaches, dizziness, and taste disturbances have also been reported. Before dental surgery, consult a doctor due to the risk of osteonecrosis of the jaw, and maintain good oral hygiene. This medication may interfere with the absorption of calcium supplements or antacids, and a gap of at least 30 minutes should be maintained between doses. Caution should also be taken with concurrent use of aspirin or non-steroidal anti-inflammatory drugs as they may increase the risk of gastrointestinal irritation. During pregnancy, the risk to the fetus may exist; therefore, it should be taken only when necessary, and caution is needed for nursing mothers. It is not recommended for children or patients with severe renal impairment. In cases of overdose, symptoms such as hypocalcemia and gastrointestinal irritation may occur; consult a healthcare professional immediately. Understanding and adhering to the method of administration and precautions can ensure safe use.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • dysphagia
  • odynophagia
  • retrosternal pain
  • heartburn
Show 44 more
  • abdominal pain
  • nausea
  • indigestion
  • constipation
  • diarrhea
  • flatulence
  • acid reflux
  • vomiting
  • abdominal distension
  • gastritis
  • musculoskeletal pain
  • muscle cramp
  • headache
  • dizziness
  • taste disturbance
  • rash
  • erythema
  • anastomotic ulcer
  • urticaria
  • angioedema
  • hypersensitivity reaction
  • myalgia
  • fatigue
  • weakness
  • fever
  • symptoms of hypocalcemia
  • peripheral edema
  • oropharyngeal ulcer
  • gastric ulcer
  • duodenal ulcer
  • localized jaw necrosis
  • joint swelling
  • low-energy fracture of the femoral neck
  • dizziness
  • vertigo
  • itching
  • hair loss
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • uveitis
  • scleritis
  • episcleritis
  • external auditory canal cholesteatoma
  • nasopharyngitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is important to store it at room temperature between 1 and 30 degrees Celsius and avoid direct sunlight to safely maintain the drug's effectiveness.

Appearance and packaging

Appearance

White to light yellow rectangular tablets

Package unit

4 tablets/Alu-Alu

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.